F16.920

Clinical Causes: Ingestion of hallucinogenic substances such as LSD, psilocybin mushrooms, peyote, or mescaline Use of synthetic hallucinogens like DMT (Dimethyltryptamine) or 2C-B Accidental or recreational use of hallucinogens during social activities or spiritual practices Misuse due to peer influence or curiosity about altered states of consciousness

Key Symptoms: Visual or auditory hallucinations, experiencing sights or sounds that aren't present Altered perception of time and space Enhanced sensory experiences or distortions Dilated pupils Increased heart rate and blood pressure Dizziness or loss of coordination Elevated mood, anxiety, or paranoia Nausea or gastrointestinal discomfort Sweating or chills

Diagnosis Path: Diagnosing hallucinogen intoxication involves a comprehensive clinical assessment. Medical professionals typically evaluate the patient’s recent history of substance use, observe physical symptoms, and consider the setting. Laboratory tests like blood or urine analysis may support diagnosis, but often, diagnosis relies on clinical presentation alone. It’s essential to differentiate uncomplicated intoxication from more severe or complicated cases involving mental health issues or physical health risks.

Treatment Protocols: Management of uncomplicated hallucinogen intoxication generally focuses on supportive care. This may include ensuring a safe environment, monitoring vital signs, and providing reassurance during the experience. In most cases, symptoms resolve on their own within a few hours. Treating any accompanying anxiety or agitation with calming techniques or medications may be considered. Importantly, healthcare providers evaluate for potential risks such as self-harm, injuries, or development of mental health conditions that may require further intervention.